IMC Chicago’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.2M Sell
111,800
-5,900
-5% -$730K ﹤0.01% 1087
2025
Q4
$14.8M Buy
117,700
+23,300
+25% +$3.04M 0.01% 986
2025
Q3
$13.8M Buy
94,400
+29,700
+46% +$4.49M 0.01% 965
2025
Q2
$10.1M Sell
64,700
-7,700
-11% -$1.22M ﹤0.01% 1010
2025
Q1
$11.9M Buy
72,400
+44,000
+155% +$7.32M 0.01% 810
2024
Q4
$4.63M Buy
28,400
+1,100
+4% +$197K ﹤0.01% 1287
2024
Q3
$5.33M Buy
+27,300
New +$5.03M ﹤0.01% 1103

Other funds holding ZTS

IMC Chicago's ZTS Position: Q1 2026 in Review

IMC Chicago reduced its Zoetis (ZTS) stake by 59% in Q1 2026, selling an estimated $2.53M and leaving 13,989 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

IMC Chicago first reported a position in ZTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.53M in Q2 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • IMC Chicago held 13,989 shares of Zoetis worth $1.65M as of Q1 2026.
  • IMC Chicago sold 20,467 Zoetis shares in Q1 2026, an estimated $2.53M.
  • Zoetis made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2765 holding.
  • IMC Chicago first reported a position in Zoetis in Q1 2025 and has held it in 5 quarters since.
  • IMC Chicago's Zoetis position peaked at $5.53M in Q2 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.